Physician profile
Ryan R Bell
NPI 1184803827
$719.29
in general payments reported to CMS, 2019-2025
20 companies · $86.30 in 2025
The $86.30 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $89.59 · 2021: $116 · 2022: $72.34 · 2023: $174 · 2024: $57.23 · 2025: $86.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $143.62 | 2019-2023 | |
| Sanofi Pasteur INC. | $117.81 | 2019-2023 | |
| Organon LLC | $51.53 | 2022-2025 | Nexplanon |
| Cranial Technologies, INC | $49.45 | 2020-2022 | |
| Boston Scientific Corporation | $48.15 | 2020-2024 | Wavewriter Alpha Prime 16 |
| Verrica Pharmaceuticals INC. | $40.94 | 2023-2024 | Ycanth |
| Seqirus USA INC | $31.63 | 2022-2025 | Flucelvax |
| Ironshore Pharmaceuticals INC. | $30.08 | 2019-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $30.01 | 2023-2025 | Rotateq, Gardasil 9, Pneumovax 23 |
| Abbott Laboratories | $24.81 | 2025 | Id Now Instrument |
| Corium, LLC | $21.17 | 2023 | Azstarys |
| Acadia Pharmaceuticals INC | $20.15 | 2025 | Daybue |
| Ultragenyx Pharmaceutical INC. | $18.42 | 2022 | |
| Sobi, INC | $16.78 | 2021 | |
| Adlon Therapeutics L.P. | $15.11 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.86 | 2023 | Flumist Quadrivalent |
| Tris Pharma INC | $14.74 | 2019 | |
| Abbvie INC. | $13.81 | 2023 | Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $12.05 | 2022 | |
| Quidel Corporation | $4.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.